CARMAT Aktie
0,87EUR | -0,10EUR | -10,31% |
WKN DE: A1C017 / ISIN: FR0010907956
Aktionärsstruktur
Inhaber | in % |
---|---|
Armistice Capital LLC | 139,66 |
Freefloat | 76,86 |
Streeterville Capital LLC | 13,53 |
Orca Capital AG | 7,25 |
Millennium Management LLC | 4,81 |
Ridgewood Investments LLC | 4,75 |
XTX Topco Ltd. | 2,39 |
Sigma Wave Ltd. | 2,33 |
Two Sigma Securities LLC | 1,63 |
Citadel Securities GP LLC | 1,03 |
EP Wealth Advisors LLC | 0,72 |
HRT Financial LP (US) | 0,71 |
Virtu Financial LLC | 0,61 |
Renaissance Technologies LLC | 0,60 |
Sabby Management LLC | 0,54 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2018 | 2019 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 90 | 107 | 160 | 179 | 182 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,01 | 0,00 | 0,02 |
Bilanz (in Mio. EUR) - Aktiva
2018 | 2019 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 31 | 59 | 62 | 78 | 42 |
Summe Anlagevermögen | 6 | 6 | 7 | 7 | 11 |
Summe Aktiva | 37 | 65 | 69 | 85 | 53 |
Bilanz (in Mio. EUR) - Passiva
2018 | 2019 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 29 | 40 | 83 | 83 | 98 |
Summe Eigenkapital | 7 | 24 | -14 | 2 | -45 |
Summe Passiva | 37 | 65 | 69 | 85 | 53 |
Adresse
36, avenue de l'Europe, 78140 Vélizy-Villacoublay | |
Telefon | +33 (1) 39-45-64-50 |
Fax | +33 (1) 39-45-64-51 |
Internet | http://www.carmatsa.com |
Management
Alexandre Eleonore
Director-Manufacturing |
Christian Latrémouille
Director-Surgical Affairs |
David Coti
Director |
Florent Battistella
Independent Director |
Francesco Arecchi
Director-Global Market Development |
Jean-Luc Lemercier
Independent Director |
John B. Hernandez
Independent Director |
Laurent Kirsch
Independent Director |
Marc Grimmé
Director-Research & Development |
Marie Pierre Merle Beral
Director |
Michael Joseph Mack
Independent Director |
Paolo Rampulla
Director |
Pascale d’Arbonneau
Chief Financial & Administrative Officer |
Pierre Bastid
Chairman |
Piet Jansen
Chief Medical Officer |
Raouia Bouyanzer
Director-Human Resources |
Stéphane Piat
Chief Executive Officer & Director |
Thierry Dupoux
Senior Director-Quality Assurance |